1. Stocks
    2. /
  2. Johnson & Johnson (NYSE: JNJ)
    3. /

Johnson & Johnson (NYSE: JNJ) Share Price and News

$201.93 $-0.55 (-0.3%) 6 December 2025 at 8:00:00 am AEDT

Johnson & Johnson Chart and Price Data

About Johnson & Johnson

Last updated 06-12-2025, 08:00:00am AEDT
Current Price $201.93
Change $-0.55 (-0.3%)
Close Price $201.93
Open Price $202.98
Bid $201.93
Ask $202.00
Day Range $200.81 - $203.45
Year Range $140.68 - $207.81
Volume 7,785,552
Average Volume 8,725,625
Market Cap $486,509,949,000.00
Earnings Per Share $10.36

    • Johnson & Johnson (NYSE: JNJ)
    Latest News

    health worker wearing personal protective equipment and gesturing stop with her hands
    International Stock News

    U.S. gives Johnson & Johnson's COVID-19 vaccine a timeout

    | Cory Renauer

    Out of an abundance of caution, the FDA and CDC have recommended a pause in the use of the only…

    Read more »

    Five different piggy banks, indicating a diverse share portfolio.
    ETFs

    2 top ASX ETFs to buy right now

    | Sebastian Bowen

    The iShares S&P 500 ETF (ASX: IVV) is one of two ASX ETFs to buy today for ASX share portfolio…

    Read more »

    coronavirus vaccine represented by gloved hand drawing down from syringe
    International Stock News

    Johnson & Johnson coronavirus vaccine wins FDA authorisation

    | Eric Volkman

    The big pharmaceutical company's jab has some important advantages.

    Read more »

    Cash piled up in the middle of a bear trap symbolising risky investments
    International Stock News

    Why Moderna Is Less Risky Than You Think

    | Manali Bhade

    Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

    Read more »

    doctor giving little boy vaccine injection in his arm
    International Stock News

    Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

    | Brian Orelli, PhD

    The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

    Read more »

    doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
    International Stock News

    The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

    | Keith Speights

    Hint: It's not Moderna.

    Read more »

    CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
    International Stock News

    Coronavirus vaccine race: 7 key things you'll want to know

    | Keith Speights

    Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

    Read more »

    A businessman holding a world globe in one hand, representing global investment.
    Technology Shares

    3 exotic ASX tech ETFs you might want to add to your portfolio today

    | Sebastian Bowen

    Want exposure to tech shares? Feeling offput by high valuations? Use these 3 ASX tech ETFs to solve these problems…

    Read more »

    covid-19 vaccine
    International Stock News

    How to invest in coronavirus vaccine stocks

    | Keith Speights

    Just follow these three simple steps.

    Read more »

    woman sitting at desk looking at calculator
    International Stock News

    This is the one investment Warren Buffett says almost everyone should make

    | Christy Bieber

    His advice is simple and easy to follow.

    Read more »

    Blue gloved hands holding up vials with covid vaccine labels
    International Stock News

    In the race for a coronavirus vaccine, can there be multiple winners?

    | Adria Cimino

    Demand says we may need several players crossing the finish line.

    Read more »

    coronavirus swab
    International Stock News

    Johnson & Johnson to launch late-stage coronavirus vaccine trials in September

    | Eric Volkman

    The company aims to recruit 60,000 participants for the study.

    Read more »

    Profile

    since

    Note